View Item 

Show simple item record

The Effect of Sacral Neuromodulation on Anticholinergic Use and Expenditures in a Privately Insured Population

dc.contributor.authorAnger, Jennifer T.en_US
dc.contributor.authorCameron, Anne P.en_US
dc.contributor.authorMadison, Rodgeren_US
dc.contributor.authorSaigal, Christopher S.en_US
dc.contributor.authorClemens, J. Quentinen_US
dc.date.accessioned2014-03-05T18:19:02Z
dc.date.available2015-03-02T14:35:34Zen_US
dc.date.issued2014-01en_US
dc.identifier.citationAnger, Jennifer T.; Cameron, Anne P.; Madison, Rodger; Saigal, Christopher S.; Clemens, J. Quentin (2014). "The Effect of Sacral Neuromodulation on Anticholinergic Use and Expenditures in a Privately Insured Population." Neuromodulation: Technology at the Neural Interface (1): 72-74.en_US
dc.identifier.issn1094-7159en_US
dc.identifier.issn1525-1403en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106102
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherUS Government Publishing Officeen_US
dc.subject.otherClaims Dataen_US
dc.subject.otherI Ngenix (I3)en_US
dc.subject.otherCosten_US
dc.subject.otherOveractive Bladderen_US
dc.titleThe Effect of Sacral Neuromodulation on Anticholinergic Use and Expenditures in a Privately Insured Populationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelNeurology and Neurosciencesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106102/1/ner12062.pdf
dc.identifier.doi10.1111/ner.12062en_US
dc.identifier.sourceNeuromodulation: Technology at the Neural Interfaceen_US
dc.identifier.citedreferenceSaigal CS, Joyce GF, Geschwind SA, Litwin MS. Methods. In: Litwin MS, Saigal CS, eds. Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Publishing Office, 2004; NIH Publication No. 04‐5512, pp. 283 – 316.en_US
dc.identifier.citedreferenceWatanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan SD. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology 2010; 76: 835 – 840.en_US
dc.identifier.citedreferenceSiddiqui NY, Amundsen CL, Visco AG, Myers ER, Wu JM. Cost‐effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol 2009; 182: 2799 – 2804.en_US
dc.identifier.citedreferenceSiddiqui NY, Wu JM, Amundsen CL. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodyn 2010; 29 ( Suppl 1 ): S18 – S23.en_US
dc.identifier.citedreferenceLeong RK, de Wachter SGG, Joore MA, van Kerrebroeck PEV. Cost‐effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder. BJU Int 2011; 108: 558 – 564.en_US
dc.identifier.citedreferenceSiddiqui NY, Amundsen CL, Visco AG, Myers ER, Wu JM. Cost‐effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol 2009; 182: 2944 – 2950.en_US
dc.identifier.citedreferenceAboseif SR, Kim DH, Rieder JM et al. Sacral neuromodulation: cost considerations and clinical benefits. Urology 2007; 70: 1069 – 1073.en_US
dc.identifier.citedreferenceCameron AP, Anger JT, Madison R, Saigal CS, Clemens JQ. National trends in the usage and success of sacral nerve stimulation. J Urol 2011; 185: 970 – 975.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ner12062.pdf
Size:
75.98KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.